Little known fact: When I was first writing the "Herb on TheStreet" column for TheStreet in 1998 Dow Jones protested. They claimed it was a rip-off of Heard on the Street. TheStreet fought back with a simple argument: My name is Herb and I write for TheStreet.
Which gets us to where we are today: The formal return of Herb on TheStreet at TheStreet.
This is where you'll find pretty much everything I do in 140 characters or more. Below this piece is pretty much everything I've written since I rejoined TheStreet. Above - everything new. Once the Reality Check newsletter starts, you'll also find light versions of what appear in the newsletter. It'll be a juggle that will evolve.
Must Read: Greenberg: Moral of The 3-D Printing Story
You can subscribe through an RSS Feed or, if you prefer to have it pushed to your email, simply email me at firstname.lastname@example.org and we'll add you to the list.
As always, I welcome your comments, criticisms, observations, tips and ideas.
Thanks for your patronage,
-- Written by Herb Greenberg
09/18/14 - 09:34 AM EDT
09/16/14 - 12:22 PM EDT
09/12/14 - 12:06 PM EDT
09/09/14 - 11:27 AM EDT
09/08/14 - 01:00 PM EDT
11/25/15 - 13:09 PM EST
11/25/15 - 12:59 PM EST
11/24/15 - 08:30 AM EST
11/23/15 - 08:30 AM EST
11/23/15 - 01:00 AM EST
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.
Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.